This is in agreement with our own results, where upregulation of C1QA, C1QC, and CFHR2 in newly diagnosed PCa patients is suggestive of the involvement of tumour inflammatory microenvironment, which may act as a mediator of tumour progression and angiogenesis (Figure 3). The gene discussed is CFHR2; the disease is neoplasm.